SecBot SecBot
PRESS-RELEASE ·Filed Mar 2, 2026

RDNT

RadNet, Inc.
BULLISH
Impact 8/10
Horizonmonths Processed8mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight ▲ Bullish

Traders should monitor the Q3 2026 timeline for AI integration across RadNet’s network, which could yield measurable productivity gains and margin expansion. The $140M combined ARR target implies strong growth in RadNet’s digital health segment, potentially re-rating the stock if execution is on track.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$75.22
T+0 close · Mar 2, 2026 · via day close
Latest settled
−28.05%
T+60 · $54.12
Vs SPY
−37.38%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 2 $75.22entry
  2. T+1 · 9mo ago −3.51%α −2.60% · $72.58
  3. T+5 · 8mo ago −17.14%α −15.93% · $62.33
  4. T+20 · 8mo ago −25.90%α −17.96% · $55.74
  5. T+60 · 6mo ago −28.05%α −37.38% · $54.12
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RadNet has acquired Paris-based Gleamer, a leading radiology AI company, for up to €230 million in an all-cash deal. The acquisition integrates Gleamer into DeepHealth, RadNet’s AI subsidiary, creating the world’s largest provider of clinical AI solutions in radiology with a combined ARR expected to reach $140 million by end of 2026. The move aims to enhance automation in high-volume imaging workflows and drive cost efficiencies across RadNet’s network starting in Q3 2026.

Key Financial Metrics

Deal Value
$250.0M

Key Facts

  • RadNet acquired Gleamer SAS, a Paris-based radiology AI company, to be integrated into its subsidiary DeepHealth.
  • The acquisition is valued at up to €230 million in an all-cash transaction, including a post-closing milestone payment.
  • Gleamer had over 700 customer contracts in 44 countries and achieved a compound annual growth rate in ARR exceeding 90% from 2022 to 2025.
  • Gleamer is expected to generate approximately $30 million in ARR in 2026.
  • Combined entity (DeepHealth + Gleamer) anticipates achieving ARR approaching or exceeding $140 million by end of 2026.
  • Integration of Gleamer’s AI into RadNet’s network is expected to drive productivity gains, particularly in X-ray, which accounts for nearly 25% of RadNet’s imaging volume.
  • Full deployment across RadNet’s operations expected by Q3 2026, enabling AI-driven triage and draft reporting.

Financial Impact

Up to €230 million (~$250 million) cash outlay; Gleamer contributing ~$30M ARR in 2026, with combined DeepHealth business projected to reach $140M ARR by year-end.

cash_flowrevenueoperating_efficiencyai_adoption_rate

Risk Factors

  • Integration risk: Combining two AI platforms and teams across geographies may delay synergy realization.
  • Cash outflow of ~$250M could pressure liquidity if not offset by operating cash flow or financing.
  • Forward-looking ARR projections are non-GAAP and subject to customer retention and execution risk.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3247141

US Market Status

Market Closed · Opens Wed (14h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 2, 2026